Oligonucleotide Synthesis Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Oligonucleotide Synthesis Market By Product (Synthesized oligonucleotides, Reagents, Equipment), By Application (Diagnostics, Research, Therapeutics), By End-Users (Diagnostic Laboratories, Research Institutes, Biotechnology & Pharmaceutical Companies), and Geography (North America, Latin America, Europe, Middle East and Africa, Asia Pacific)

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global Oligonucleotide Synthesis Market size was estimated at USD 3.2 Bn in 2021, growing at a CAGR of 10.8% during the forecast period 2021-2027. Oligonucleotide Synthesis is synthesis of short fragments of the nucleic acids which have a defined chemical structure. This process of chemical synthesis enables provide a rapid access to the custom-made oligonucleotides. The building blocks are coupled sequentially which further helps in growing the customized oligonucleotide chain. In October 2017, Integrated DNA Technologies has acquired oligonucleotide manufacturing business of GeneWorks Pty Ltd. (GeneWorks) in Australia. The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa). The research report on Oligonucleotide Synthesis Market contains the COVID-19 in light of changes in consumer behaviour and demand, purchasing patterns, supply chain re-routing, market dynamics, and government involvement. The revised report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.


Oligonucleotide Synthesis Market

MARKET SUMMARY
-
10.8% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 10.8%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Oligonucleotide Synthesis Market

  • The report on the global Oligonucleotide Synthesis Market gives historical, current, and future market sizes (US$ Bn) based on the product, application, end-user and Geography.
  • Global Oligonucleotide Synthesis Marketgives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Market Key Players
  • Thermo Fisher Scientific Inc. (U.S)
  • Integrated DNA Technologies, Inc. (U.S)
  • Sigma-Aldrich Corporation (U.S)
  • GE Healthcare (U.S)
  • Eurofins Genomics (Germany)
  • Nitto Denko Avecia Inc. (Japan)
Drivers And Restraints

Oligonucleotide Synthesis Market

The increase in adoption of advanced technologies are expected to increase the growth of the market. The surge in initial investments in research and development, companies focused on novel technologies are anticipated to fuel the growth of the market. Furthermore, these R&D activities are adding scope for the advent of new products which is likely to enhance the growth of the market, providing opportunities to the manufactures. The increasing government support in developing technologies such as the oligonucleotide synthesis technology and the genomic technologies is enriching the growth of the market. Personalized medicine is playing a vital role, expected to add fuel for the growth of the market. However, the stringent government regulations in approval of oligonucleotide-based therapeutics are expected to hamper the growth of the market.


North-America got significant share

Oligonucleotide Synthesis Market

Geographically, global oligonucleotide synthesis market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North Americaoligonucleotide synthesis market is dominant and is expected to hold its position over the forecasted period. The soaring advancements in the healthcare sector, increased investments in biotechnology is expected to witness the growth of the market. The increasing R&D activities, sophisticated infrastructure expected to fuel the market. The Asia Pacific oligonucleotide synthesis market is expected to accelerate the growth in the forecasted period owing to emerging economies such as China and India, which enables increase the growth of the market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast.
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market.
Segmentation

Oligonucleotide Synthesis Market


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Thermo Fisher Scientific Inc. (U.S)
  • Integrated DNA Technologies, Inc. (U.S)
  • Sigma-Aldrich Corporation (U.S)
  • GE Healthcare (U.S)
  • Eurofins Genomics (Germany)
  • Nitto Denko Avecia Inc. (Japan)
  • Agilent Technologies Inc. (U.S)

Description

The global Oligonucleotide Synthesis Market size was estimated at USD 3.2 Bn in 2021, growing at a CAGR of 10.8% during the forecast period 2021-2027. Oligonucleotide Synthesis is synthesis of short fragments of the nucleic acids which have a defined chemical structure. This process of chemical synthesis enables provide a rapid access to the custom-made oligonucleotides. The building blocks are coupled sequentially which further helps in growing the customized oligonucleotide chain. In October 2017, Integrated DNA Technologies has acquired oligonucleotide manufacturing business of GeneWorks Pty Ltd. (GeneWorks) in Australia. The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa). The research report on Oligonucleotide Synthesis Market contains the COVID-19 in light of changes in consumer behaviour and demand, purchasing patterns, supply chain re-routing, market dynamics, and government involvement. The revised report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX